Michael Li

7PUBLICATIONS
12CO-AUTHORS
Pacific Peoples cultural determinants of healthCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPlant pathologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 18, 2026
Pruritus Is Frequent and Persistent and Impacts Quality of Life Among Patients With Primary Sclerosing Cholangitis.

|Aug 08, 2025
Immunotherapy and Cirrhosis: Expanding Child-Pugh Boundaries in Liver Cancer.

Michael Li, Robin K Kelley

|Nov 20, 2024
Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma-a real-world, multicenter study.

Michael Li, Lindsay M Hannan, Lipika Goyal

|Oct 17, 2022
Diagnosis and Management of Drug-Induced Liver Injury After the Use of Polygonum multiflorum.

Ali Zahir, Michael Li, Ryan M Gill

|Oct 28, 2021
Effect of corticosteroid dosing on outcomes in high-grade immune checkpoint inhibitor hepatitis.

Michael Li, Danny Wong, Alexander S Vogel

|Sep 05, 2020
Outcomes after resumption of immune checkpoint inhibitor therapy after high-grade immune-mediated hepatitis.

Michael Li, Jordan S Sack, Osama E Rahma

Pageof 2

Frequent Collaborators

1 joint publications

Shilpa Grover

1 joint publications

Ahmad Najdat Bazarbashi

1 joint publications

Marvin Ryou

1 joint publications

Ali Zahir